Cutler Group LP Kezar Life Sciences, Inc. Call Options Transaction History

Cutler Group LP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 01, 2023	BUY	$3.13 - $7.31 $15,337 - $35,819	4,900 Added 4900.0%	5,000 $1,000
Q4 2022 Feb 07, 2023	SELL	$6.39 - $8.8 $139,941 - $192,720	-21,900 Reduced 99.55%	100 $0
Q3 2022 Oct 25, 2022	SELL	$7.99 - $10.75 $176,579 - $237,575	-22,100 Reduced 50.11%	22,000 $0
Q2 2022 Aug 04, 2022	BUY	$4.58 - $17.13 $166,254 - $621,819	36,300 Added 465.38%	44,100 $16,000
Q1 2022 Apr 14, 2022	BUY	$12.3 - $18.33 $70,110 - $104,480	5,700 Added 271.43%	7,800 $6,000
Q4 2021 Jan 18, 2022	BUY	$7.44 - $16.72 $14,136 - $31,767	1,900 Added 950.0%	2,100 $14,000
Q3 2020 Oct 27, 2020	SELL	$4.36 - $5.5 $9,592 - $12,100	-2,200 Reduced 91.67%	200 $0
Q2 2020 Jul 22, 2020	BUY	$3.6 - $7.75 $8,640 - $18,600	2,400 New	2,400 $1,000

38.4M

13.8K

600

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $513M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.